SAGENT PHARMACEUTICALS INC - COM (SGNT)

CUSIP: 786692103

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
21,974,006
Share change
+225,556
Total reported value
$557,697,138
Price per share
$25.38
Number of holders
98
Value change
+$6,150,086
Number of buys
3
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 786692103?
CUSIP 786692103 identifies SGNT - SAGENT PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SAGENT PHARMACEUTICALS INC - COM (SGNT) as of Q4 2013

As of 31 Dec 2013, SAGENT PHARMACEUTICALS INC - COM (SGNT) was held by 98 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,974,006 shares. The largest 10 holders included FRANKLIN RESOURCES INC, MORGAN STANLEY, VANGUARD GROUP INC, CREDIT SUISSE AG/, BlackRock Fund Advisors, JPMORGAN CHASE & CO, Sectoral Asset Management Inc, PENN CAPITAL MANAGEMENT CO INC, NWQ INVESTMENT MANAGEMENT COMPANY, LLC, and GOLDMAN SACHS GROUP INC. This page lists 98 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.